Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma
- 1 December 2018
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 74 (6) , 805-809
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Role of Cytoreductive Nephrectomy: European Association of Urology Recommendations in 2016European Urology, 2016
- Safety and Efficacy of Pazopanib Therapy Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerJAMA Oncology, 2016
- Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trialThe Lancet Oncology, 2016
- EAU Guidelines on Renal Cell Carcinoma: 2014 UpdateEuropean Urology, 2015
- Cytoreductive Nephrectomy in Patients with Synchronous Metastases from Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database ConsortiumEuropean Urology, 2014
- The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal CancerEuropean Urology, 2011
- Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomyBJU International, 2010
- Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy?Cancer, 2010
- Cytoreductive Nephrectomy in Patients With Metastatic Renal Cancer: A Combined AnalysisJournal of Urology, 2004
- Survival and Prognostic Stratification of 670 Patients With Advanced Renal Cell CarcinomaJournal of Clinical Oncology, 1999